Atea Pharmaceuticals shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $119k | 36k | 3.35 |
| 2024-06-30 | $114k | 34k | 3.31 |
| 2024-03-31 | $111k | 28k | 4.04 |
| 2023-12-31 | $73k | 24k | 3.05 |
| 2023-09-30 | $58k | 20k | 3.00 |
| 2023-06-30 | $111k | 30k | 3.74 |
| 2022-12-31 | $2.4k | 500 | 4.81 |
| 2022-09-30 | $3.6k | 695 | 5.13 |
| 2022-06-30 | $11k | 1.3k | 8.00 |
| 2022-03-31 | $219k | 30k | 7.21 |
| 2021-12-31 | $463k | 52k | 8.95 |
| 2021-09-30 | $9.9M | 282k | 35.06 |
| 2021-06-30 | $6.1k | 278 | 21.93 |
| 2021-03-31 | $282k | 4.6k | 61.78 |
| 2020-12-31 | $316k | 7.6k | 41.80 |